Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | matrix metallopeptidase 1 (interstitial collagenase) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Matrixin family protein | matrix metallopeptidase 1 (interstitial collagenase) | 403 aa | 401 aa | 27.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Thioredoxin reductase | 0.0202 | 0.4385 | 0.4385 |
Leishmania major | hypothetical protein, conserved | 0.0391 | 1 | 1 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0391 | 1 | 1 |
Toxoplasma gondii | thioredoxin reductase | 0.0202 | 0.4385 | 0.4114 |
Loa Loa (eye worm) | matrixin family protein | 0.0064 | 0.0269 | 0.0269 |
Loa Loa (eye worm) | hypothetical protein | 0.0391 | 1 | 1 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.007 | 0.0461 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.007 | 0.0461 | 0.5 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.0096 | 0.1221 | 0.1221 |
Trichomonas vaginalis | glutathione reductase, putative | 0.007 | 0.0461 | 0.5 |
Trypanosoma brucei | trypanothione reductase | 0.0202 | 0.4385 | 1 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.007 | 0.0461 | 0.0461 |
Treponema pallidum | NADH oxidase | 0.007 | 0.0461 | 0.5 |
Plasmodium vivax | glutathione reductase, putative | 0.0202 | 0.4385 | 0.4114 |
Brugia malayi | Kringle domain containing protein | 0.0391 | 1 | 1 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.007 | 0.0461 | 1 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.007 | 0.0461 | 0.5 |
Plasmodium falciparum | thioredoxin reductase | 0.0202 | 0.4385 | 0.4114 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0202 | 0.4385 | 0.4114 |
Loa Loa (eye worm) | matrixin family protein | 0.0058 | 0.0113 | 0.0113 |
Trichomonas vaginalis | mercuric reductase, putative | 0.007 | 0.0461 | 0.5 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0391 | 1 | 1 |
Onchocerca volvulus | Matrilysin homolog | 0.0058 | 0.0113 | 0.0113 |
Leishmania major | trypanothione reductase | 0.0202 | 0.4385 | 0.4114 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.007 | 0.0461 | 0.0461 |
Onchocerca volvulus | 0.0391 | 1 | 1 | |
Loa Loa (eye worm) | glutathione reductase | 0.0202 | 0.4385 | 0.4385 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.007 | 0.0461 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0391 | 1 | 1 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.007 | 0.0461 | 0.0461 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0058 | 0.0113 | 0.0113 |
Plasmodium falciparum | glutathione reductase | 0.0202 | 0.4385 | 0.4114 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.007 | 0.0461 | 0.5 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.007 | 0.0461 | 0.0461 |
Schistosoma mansoni | hypothetical protein | 0.0391 | 1 | 1 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0391 | 1 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0202 | 0.4385 | 0.4114 |
Brugia malayi | glutathione reductase | 0.0202 | 0.4385 | 0.4385 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0391 | 1 | 1 |
Brugia malayi | Matrixin family protein | 0.0064 | 0.0269 | 0.0269 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0202 | 0.4385 | 0.4385 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0391 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.007 | 0.0461 | 0.5 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.007 | 0.0461 | 0.5 |
Toxoplasma gondii | kringle domain-containing protein | 0.0391 | 1 | 1 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.0096 | 0.1221 | 0.1221 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0202 | 0.4385 | 0.4385 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0202 | 0.4385 | 0.4385 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0202 | 0.4385 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 730 nM | Inhibition of rat skin type I collagen degradation by purified human lung fibroblast collagenase | ChEMBL. | 8258825 |
IC50 (binding) | = 730 nM | Inhibition of rat skin type I collagen degradation by purified human lung fibroblast collagenase | ChEMBL. | 8258825 |
IC50 (binding) | = 810 nM | Inhibition of rat skin type I collagen degradation by purified human lung fibroblast collagenase | ChEMBL. | 8258825 |
IC50 (binding) | = 810 nM | Inhibition of rat skin type I collagen degradation by purified human lung fibroblast collagenase | ChEMBL. | 8258825 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.